In another study, the comparison of SphK1 expression levels in tumor tissues and adjacent normal tissue samples revealed that patients with hepatocellular carcinoma (HCC) had significantly upregulated SphK1 levels, and higher SphK1 expression was correlated with shorter overall survival times. Here, SPHK1 is linked to hepatocellular carcinoma.